DNA Chip Research: Independent Company Executives Declaration
DNA Chip Research: Notice of Convening Regular Shareholders' Meeting for the Year 2024.
DNA Chip Research: Financial results briefing for the fiscal year ending 2024/3
DNA Chip Research: Summary of financial results for the fiscal year ending March 2024 [Japanese GAAP] (unconsolidated)
DNA Chip Research: Notice regarding head office relocation
DNA Chip Research: Notice regarding the recording of non-operating income (subsidy/subsidy income)
DNA Chip Research: Notice regarding election decisions for newly appointed director candidates and director candidates who are alternate members of the Audit and Supervisory Committee
DNA Chip Research: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)
DNA Chip Research: Change Report
DNA Chip Research Institute: Notice Concerning Completion of Payment Related to Issuance of New Shares through Third-Party Allotment
DNA Chip Research: Extraordinary Report
DNA Chip Research Institute: Notice of insurance coverage and commencement of testing for the 7-gene version of the “Lung Cancer Compact Panel Dx Multi-Companion Diagnosis System” (medical device program)
DNA Chip Research Institute: Corrected Securities Registration Form (Embedded Method)
DNA Chip Laboratory: Confirmation
DNA Chip Research Institute: Quarterly Report - 25th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
DNA Chip Research Institute: Corrected Securities Registration Form (Embedded Method)
DNA Chip Research: Notice regarding the conclusion of a capital and business partnership agreement, issuance of new shares through third-party allotment, and changes in the major shareholder and the largest shareholder who is the main shareholder
DNA Chip Research: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
DNA Chip Research: Notice regarding revisions to earnings forecasts
DNA Chip Research Institute: Securities Registration Form (embedded method)
No Data